Lv11
30 积分 2024-04-20 加入
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
5小时前
待确认
Bispecific T cell engager therapy for refractory rheumatoid arthritis
7天前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
12天前
已完结
In vivo engineering chimeric antigen receptor immune cells with emerging nanotechnologies
14天前
已完结
In vivo CAR T-cell generation in non-human primates using lentiviral vectors displaying a multi-domain fusion ligand
17天前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
25天前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
1个月前
已完结
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
1个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
1个月前
已完结
皖公网安备34019202002308
